4/A
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-19-025125
CBO & EVP sold 832 shares at $65.52 ($54,513)
- CBO & EVP acquired 7,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Kassberg Thomas Richard · CBO & EVP
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-03-01 | Grant or award : show line 1 in the form | +7,000 | 90,306 | D | ||
| 2019-03-05 | Sale : show line 2 in the form | −832 | $65.52 | $54,513 | 89,474 | D |
| Open-market sales · 832 sh · avg $65.52 · $54,513 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2019-03-01 | Grant or award : show line 3 in the form Stock Option (Right to Buy) | +21,500 | $67.55 | 2029-03-01 | 21,500 | 21,500 | D |
Loading xslF345X03/doc4a.xml…